Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Aptose Biosciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$2.67 | -$2.67 | -$2.67 |
| Q2 2025 | 1 | -$2.74 | -$2.74 | -$2.74 |
| Q3 2025 | 1 | -$1.95 | -$1.95 | -$1.95 |
| Q4 2025 | 1 | -$2.10 | -$2.10 | -$2.10 |
Aptose Biosciences Inc. Earnings Date And Information
Aptose Biosciences Inc. last posted its earnings results on Monday, May 12th, 2025. The company reported $-2.60689 earnings per share for the quarter, topping analysts' consensus estimates of $-2.67 by $0.06311. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Aptose Biosciences Inc. has generated $-6 earnings per share over the last year ($-18.94 diluted earnings per share) and currently has a price-to-earnings ratio of -0.17. Aptose Biosciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based on prior year's report dates.
Aptose Biosciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/08/2025 | Q1 2025 | N/A | -$2.61 | N/A | $0 | $0 |
| 03/28/2025 | Q4 2024 | N/A | -$0.28 | N/A | $0 | $0 |
| 11/08/2024 | Q3 2024 | N/A | -$1.24 | N/A | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$17.42 | -$1.30 | 16.12 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$24.62 | -$1.72 | 22.9 | N/A | $0 |
| 04/29/2024 | Q4 2023 | N/A | -$1.80 | N/A | N/A | $955.27 K |
| 11/09/2023 | Q3 2023 | -$64.86 | -$1.76 | 63.1 | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$62.76 | -$2.27 | 60.49 | N/A | $0 |
| 05/08/2023 | Q1 2023 | -$54.03 | -$2.22 | 51.81 | N/A | $0 |
| 03/23/2023 | Q4 2022 | N/A | -$1.62 | N/A | N/A | $0 |
| 11/01/2022 | Q3 2022 | -$54.03 | -$1.59 | 52.44 | N/A | $0 |
| 08/02/2022 | Q2 2022 | -$58.53 | -$1.72 | 56.81 | N/A | $0 |
| 05/09/2022 | Q1 2022 | -$67.53 | -$1.93 | 65.6 | N/A | $0 |
| 03/22/2022 | Q4 2021 | -$81.04 | -$4.10 | 76.94 | N/A | $0 |
| 11/12/2021 | Q3 2021 | N/A | -$1.91 | N/A | N/A | $0 |
| 08/03/2021 | Q2 2021 | -$81.04 | -$2.27 | 78.77 | N/A | $0 |
| 05/04/2021 | Q1 2021 | -$76.54 | -$2.73 | 73.81 | N/A | $0 |
| 03/23/2021 | Q4 2020 | -$72.04 | -$2.48 | 69.56 | N/A | $0 |
| 11/10/2020 | Q3 2020 | -$81.04 | -$2.31 | 78.73 | N/A | $0 |
| 08/04/2020 | Q2 2020 | -$67.53 | -$3.10 | 64.43 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aptose Biosciences Inc. Earnings: FAQ's
Aptose Biosciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based offlast year's report dates.
In the previous quarter, Aptose Biosciences Inc. (:APTO) reported $-2.60689 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.67 by $0.06311.
The conference call for Aptose Biosciences Inc.'s latest earnings report can be listened to online.
The conference call transcript for Aptose Biosciences Inc.'s latest earnings report can be read online.
Aptose Biosciences Inc. (:APTO) has a recorded net income of $-25,430,000.Aptose Biosciences Inc. has generated $-5.73 earnings per share over the last four quarters.
Aptose Biosciences Inc. (:APTO) has a price-to-earnings ratio of -0.17 and price/earnings-to-growth ratio is 0.01.